Genomind, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2020 | $6 M | No. 4 | $2 to $10 million | equity, options | SEC | |
| Jul 2018 | $21 M | No. 3 | $10 to $50 million | equity | SEC | |
| Feb 2017 | $8 M | No. 2 | $2 to $10 million | equity | SEC | |
| Apr 2014 | $21 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Genomind, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2021).
SEC Form D · Apr 2021
The industry group it chose in its notices: Other Health Care.
SEC Form D · Apr 2021
That is all the official record says: Genomind, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Genomind, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 8 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Shawn Patrick O'Brien | Mr. O'Brien is the Chief Executive Officer and the Chairman of the Board of the Issuer. | Apr 2021 |
| Stephen Patrick Haller | Mr. Haller is the Treasurer of the Issuer. | Apr 2021 |
| Tom Patrick Hess | Mr. Hess is the Chief Financial Officer and Secretary of the Issuer. | Apr 2021 |
| Gloria P. Nuss | Executive officer | Sep 2020 |
| Kip P. Olmstead | Executive officer | Sep 2020 |
| Shawn P. O'Brien | Executive officer | Sep 2020 |
| Stephen P. Haller | Executive officer | Sep 2020 |
| Thomas P. Hess | Executive officer | Sep 2020 |
| Beth E. Dozoretz | Executive officer | Dec 2018 |
| Gloria E. Nuss | Executive officer | Dec 2018 |
| Kip E. Olmstead | Executive officer | Dec 2018 |
| Ronald I. Dozoretz | Executive officer | Dec 2018 |
| Stephen E. Haller | Executive officer | Dec 2018 |
| Thomas E. Hess | Executive officer | Dec 2018 |
| Michael I. Koffler | Executive officer | Oct 2017 |
| Scott I. Storrer | Executive officer | Apr 2014 |
| Stacy E. Williams | Executive officer | Apr 2014 |
| Beth Patrick Dozoretz | Director | Apr 2021 |
| John Patrick Chadwick | Director | Apr 2021 |
| Shawn Patrick O'Brien | Mr. O'Brien is the Chief Executive Officer and the Chairman of the Board of the Issuer. | Apr 2021 |
| Shelloy Patrick Kiger | Director | Apr 2021 |
| Theresa Patrick Sexton | Director | Apr 2021 |
| Brad Patrick Lucas | Director | Dec 2020 |
| Joseph Patrick Anton | Director | Dec 2020 |
| Brad P. Lucas | Director | Sep 2020 |
| John P. Chadwick | Director | Sep 2020 |
| Joseph P. Anton | Director | Sep 2020 |
| Shawn P. O'Brien | Director | Sep 2020 |
| Theresa P. Sexton | Director | Sep 2020 |
| Beth E. Dozoretz | Director | Dec 2018 |
| John E. Chadwick | Director | Dec 2018 |
| Joseph E. Anton | Director | Dec 2018 |
| Ronald I. Dozoretz | Director | Dec 2018 |
| Theresa E. Sexton | Director | Dec 2018 |
| Michael I. Koffler | Director | Oct 2018 |
| Rina E. Wolf | Director | Oct 2018 |
| Ronald I. Dozoretz | Promoter | Dec 2018 |
| Michael I. Koffler | Promoter | Oct 2017 |
| Scott I. Storrer | Promoter | Apr 2014 |